Evidence map›Paper›PMID 29217290›Full record

ArticleSeminars in arthritis and rheumatism2018

Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).

Flora McErlane, Roberto Carrasco, Lianne Kearsley-Fleet, Eileen M Baildam, Lucy R Wedderburn, Helen E Foster, Yiannis Ioannou, S E Alice Chieng, Joyce E Davidson, Wendy Thomson and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Seminars in arthritis and rheumatism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Lef1 ablation alleviates cartilage mineralization following posttraumatic osteoarthritis induction.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  15. Pediatric uveitis: Role of the pediatrician.Frontiers in pediatrics · 2022
    Review
  16. Article
  17. Growth and puberty in children with juvenile idiopathic arthritis.Pediatric rheumatology online journal · 2021
    Review
  18. Evaluation of impaired growth plate development of long bones in skeletally immature mice by antirheumatic agents.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2021
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 1 country.

Flora McErlanePaediatric Rheumatology, Great North Children's Hospital, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK; Rheumatology, Institute Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Roberto CarrascoArthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences. Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Lianne Kearsley-FleetArthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences. Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
Eileen M BaildamPaediatric Rheumatology, Alder Hey Children's Hospital, Liverpool, UK.
Lucy R WedderburnArthritis Research UK Centre for Adolescent Rheumatology, Infection, Inflammation and Rheumatology Section, UCL GOS Institute of Child Health, London, UK.
Helen E FosterPaediatric Rheumatology, Great North Children's Hospital, Newcastle Hospitals NHS Trust, Newcastle upon Tyne, UK; Rheumatology, Institute Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK.
Yiannis IoannouArthritis Research UK Centre for Adolescent Rheumatology, Division of Medicine, University College London (UCL), London, UK.
S E Alice ChiengRheumatology, Royal Manchester Children's Hospital, Manchester, UK.
Joyce E DavidsonPaediatric Rheumatology, Royal Hospital for Children, Glasgow, UK; Paediatric Rheumatology, Royal Hospital for Sick Children, Edinburgh, UK.
Wendy ThomsonArthritis Research UK Center for Genetics and Genomics, Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences. Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Kimme L HyrichArthritis Research UK Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences. Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; NIHR Manchester Musculoskeletal Biomedical Research Unit, Central Manchester NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK. Electronic address: Kimme.hyrich@manchester.ac.uk.
Versus Arthritis · GBUniversity of Manchester · GBAlder Hey Children's Hospital · GBGreat North Children's Hospital · GBNewcastle University · GBRoyal Hospital for Children · GBRoyal Manchester Children's Hospital · GBUniversity College London · GB

Funding

Arthritis Research UK 20542Medical Research Council MR/M004600/1Medical Research Council MR/R013926/1
6 · The paper itself

Abstract

objectivesTo investigate early vertical growth patterns and factors associated with poor growth in a modern inception cohort of UK children with juvenile idiopathic arthritis (JIA) using data from the Childhood Arthritis Prospective Study (CAPS).

methodsA study period of 3 years was chosen. Children included in this analysis had a physician diagnosis of JIA and had height measurements available at both baseline and at 3-years of follow-up. Height is presented as z-scores calculated using World Health Organisation growth standards for age and gender. Growth over the 3-year period was assessed using change in z-score and height velocity. Univariable and multivariable linear regressions were used to identify factors associated with height z-score at baseline and change of height z-score at 3 years.

results568 patients were included; 65% female, median baseline age 7.4 years [interquartile range (IQR) 3.6, 11.2], median symptom duration at presentation 5.5 months [IQR 3.1, 11.6]. Height z-score decreased significantly from baseline to 3 years (p ≤ 0.0001); baseline median height z-score was -0.02 (IQR -0.71, 0.61), decreasing to -0.47 (IQR -1.12, 0.24) at 3 years. Growth restriction, defined as change of height z-score ≤-0.5, was observed in 39% of patients. At 3 years, higher baseline height z-score was the strongest predictor for a negative change in height z-score [-0.3 per unit of baseline height z-score (95% CI: -0.36, -0.24), p < 0.0001].

conclusionsAlthough overall height at 3 years after initial presentation to rheumatology is within the population norm, as a cohort, children with JIA experience a reduction of growth in height over the first 3 years of disease. Late presentation to paediatric rheumatology services is associated with lower height at presentation. However, patients with the lowest height z scores at presentation were also the most likely to see an improvement at 3 years. The impact of JIA on growth patterns is important to children and families and this study provides useful new data to support informed clinical care.

Indexed as

AdolescentAdolescent DevelopmentArthritis, JuvenileBody HeightChildChild DevelopmentChild, PreschoolFemaleHumansMaleProspective Studiesfunctional disabilityGrowth restrictionHeight velocityJuvenile idiopathic arthritisSteroids

Identifiers

PMID29217290
PMCPMC6089842
OpenAlexW2767485555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.